Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer

Abstract Background Daily adaptive radiation therapy (ART) of patients with non-small cell lung cancer (NSCLC) lowers organs at risk exposure while maintaining the planning target volume (PTV) coverage. Thus, ART allows an isotoxic approach with increased doses to the PTV that could improve local tu...

Descrición completa

Detalles Bibliográficos

Principais autores:	Lea Hoppen, Gustavo R. Sarria, Chung S. Kwok, Judit Boda-Heggemann, Daniel Buergy, Michael Ehmann, Frank A. Giordano, Jens Fleckenstein
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-02-01
Series:	Radiation Oncology
Assuntos:	Adaptive radiation therapy stage III NSCLC Isotoxic dose-escalation Isoeffective organ at risk sparing
Acceso en liña:	https://doi.org/10.1186/s13014-023-02222-7
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!